INTERAID has been developed through collaboration between ARIA (Allergic Rhinitis and its Impact on Asthma) and EAACI to utilize the Ukrainian model of shared-decision making for patients with asthma, rhinitis, or urticaria, in partnership with local physicians.

Traveling patients complete questionnaires and daily symptom-medication scores for asthma, rhinitis (MASK-air), or urticaria (CRUSE) in their native language. In compliance with GDPR, patients then authorize their physician to access the app by scanning a QR code displayed on the physician’s (or healthcare provider’s) computer. This allows the physician to view the app contents in his/her own language.